Ligand Pharmaceuticals Inc
NASDAQ:LGND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
Keong Hong Holdings Ltd
SGX:5TT
|
SG |
|
Vyborgskiy Sudostroitel'nyi Zavod PAO
MOEX:VSYD
|
RU |
|
P
|
Pepco Group NV
WSE:PCO
|
UK |
|
Buckle Inc
NYSE:BKE
|
US |
|
Posco Chemical Co Ltd
KRX:003670
|
KR |
|
Advanced Info Service PCL
OTC:AVIZF
|
TH |
|
ATAC Resources Ltd
XTSX:ATC
|
CA |
|
GNCC Capital Inc
OTC:GNCP
|
US |
|
Orient Overseas (International) Ltd
OTC:OROVY
|
HK |
|
Adomos SA
F:Y2A
|
FR |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
Wall Street
Price Targets
LGND Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LGND
is 250 USD
with a low forecast of 222.2 USD and a high forecast of 290.85 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LGND's stock price target?
Price Target
250
USD
According to Wall Street analysts, the average 1-year price target for
LGND
is 250 USD
with a low forecast of 222.2 USD and a high forecast of 290.85 USD.
What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
11%.
What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
59%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's operating income is
26%.
The projected
CAGR
for the next 3 years is
59%.
What is Ligand Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
35%
For the last 14 years the
compound annual growth rate for
Ligand Pharmaceuticals Inc's net income is
20%.
The projected
CAGR
for the next 3 years is
35%.
